Crescita Therapeutics (TSE:CTX) Trading Down 1.5%

Crescita Therapeutics Inc. (TSE:CTXGet Rating) was down 1.5% during trading on Friday . The stock traded as low as C$0.65 and last traded at C$0.65. Approximately 27,000 shares were traded during mid-day trading, an increase of 11% from the average daily volume of 24,300 shares. The stock had previously closed at C$0.66.

Crescita Therapeutics Trading Down 1.5 %

The company has a debt-to-equity ratio of 7.65, a current ratio of 3.39 and a quick ratio of 2.29. The company has a market capitalization of C$13.21 million, a price-to-earnings ratio of 16.25 and a beta of 2.07. The business has a fifty day moving average price of C$0.66 and a 200 day moving average price of C$0.69.

Crescita Therapeutics Company Profile

(Get Rating)

Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including MMPE and DuraPeel for the development of topicals containing cannabis and hemp.

Featured Stories

Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.